Inotropic Agents & Heart Disease

Inotropic agents alter the force or energy of muscular contractions. Negatively inotropic agents weaken the force of muscular contractions. Positively inotropic agents increase the strength of muscular contraction. Inotropic agents are used in hospitalized patients with acute decompensated heart failure, with reduced left ventricular ejection fraction and with signs of end-organ dysfunction in the setting of a low cardiac output, or with severe systolic heart failure awaiting heart transplant to maintain hemodynamic stability or as a bridge to decision. Discover the latest research on inotrpic agents and heart diseases here.

July 7, 2020

Antiproliferative activity of cardenolides on cell line A549: structure-activity relationship analysis

Molecular Diversity
Salvador Enrique Meneses-SagreroRamón Enrique Robles-Zepeda
July 8, 2020

Sex Differences in Clinical Characteristics and 1- and 10-Year Mortality Among Patients Hospitalized With Acute Heart Failure

The American Journal of the Medical Sciences
Wesam MullaAnan Younis
June 23, 2020

Sense and nonsense concerning biotin interference in laboratory tests

Acta Clinica Belgica
Alena Moerman, Joris R Delanghe
July 6, 2020

Optimization of amylomaltase for the synthesis of α-arbutin derivatives as tyrosinase inhibitors

Carbohydrate Research
Prakarn Rudeekulthamrong, Jarunee Kaulpiboon
July 1, 2020

Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation

The American Journal of Medicine
Steven SinghAli Ahmed
June 21, 2020
Review
Open Access

The Role of Estrogen Receptors in Cardiovascular Disease

International Journal of Molecular Sciences
Laila AryanMansoureh Eghbali
June 23, 2020

Ouabain and Marinobufagenin: Physiological Effects on Human Epithelial and Endothelial Cells

Biochemistry. Biokhimii︠a︡
E A KlimanovaS N Orlov
July 8, 2020
Review
Open Access

Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine
Mina KaramiJosé P S Henriques
July 4, 2020
Open Access

Elevated plasma phenylalanine predicts mortality in critical patients with heart failure

ESC Heart Failure
Wei-Siang ChenChung-Yu Liang
July 9, 2020

Oleandrin: A bioactive phytochemical and potential cancer killer via multiple cellular signaling pathways

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Nazia KanwalZeliha Selamoglu
June 23, 2020

Cardiovascular Effects of Energy Drinks in the Pediatric Population

Pediatric Emergency Care
Mohamad MoussaEugene Izsak
June 20, 2020
Open Access

The inotropic agent digitoxin strengthens desmosomal adhesion in cardiac myocytes in an ERK1/2-dependent manner

Basic Research in Cardiology
Camilla SchinnerJens Waschke
June 26, 2020

Phytochemical screening of Alstonia venenata leaf and bark extracts and their antimicrobial activities

Cellular and Molecular Biology
Gholamreza BagheriRyszard Amarowicz
June 24, 2020
Review

Perioperative pharmacological circulatory support in daily clinical routine

Der Anaesthesist
A HaasD A Reuter
July 7, 2020

Enhanced production and immunomodulatory activity of levan from the acetic acid bacterium, Tanticharoenia sakaeratensis

International Journal of Biological Macromolecules
Pornpun AramsangtienchaiKlaokwan Srisook

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2020 Meta ULC. All rights reserved
/feed-previews/inotropic-agents-heart-disease/ac3dcd52-2258-4b2c-b6cc-2ab2f99bae46